Bumper Offer - Urjas oil Just @ Rs. 1
Vomer O is an allopathic medicine The correct dosage of Vomer O depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Vomer O is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Vomer O is used -
Severe
Moderate
Mild
Is the use of Vomer O safe for pregnant women?
Vomer O has mild to no side effects in pregnant women.
Is the use of Vomer O safe during breastfeeding?
Vomer O can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Vomer O on the Kidneys?
Very few cases of side effects of Vomer O on kidney have been reported.
What is the effect of Vomer O on the Liver?
Vomer O has very mild side effects on the liver.
What is the effect of Vomer O on the Heart?
Vomer O may have mild side effects on the heart. Most people will never see any effect on the heart.
Vomer O should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Vomer O unless your doctor advises you to do so -
Is this Vomer O habit forming or addictive?
Vomer O does not cause addiction.
Interaction between Food and Vomer O
You can take Vomer O with food.
Interaction between Alcohol and Vomer O
Consuming Vomer O with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prilosec (omeprazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 651-653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 945-947
